BRAF mutation, colorectal cancer, Biomarker, sex, MEK inhibitor, binimetinib
cancer, diagnosis, prognosis, imaging, deep-learning
Colorectal cancer, BRAF mutation, microsatellite instability, immune checkpoint inhibitor
research biopsies, safety, tumour content, ethics, precision oncology, clinical trials.
Metastatic colorectal cancer, BRAF mutation, microsatellite instability high, deficient mismatch repair, immune checkpoint inhibitors, encorafenib, cetuximab